Published online 13 October 2008 | Nature | doi:10.1038/news.2008.1167

News: Q&A

Glowing with pride

Nature catches up with freshly-minted Nobel laureate Martin Chalfie.

This year's Nobel Prize in Chemistry went to the discoverers and developers of green fluorescent protein (GFP), widely used in biology to trace cellular processes.

Martin ChalfieNobel laureate Martin Chalfie of Columbia University in New York.University of Columbia/Eileen Barroso

Nature News caught up with an excited Martin Chalfie of Columbia University in New York, who showed that the gene for GFP could be expressed in other organisms. He shares the prize with Osamu Shimomura, now an emeritus professor at the Marine Biological Laboratory in Woods Hole, Massachusetts, and Roger Tsien at the University of California, San Diego.

How did you find out about the prize?

This is a bit of an embarrassment. A couple of days before the announcement I had been playing around with our phone. I must've hit a wrong button and changed the ring so that it turns out to be fairly faint. So I slept through the call [from the Nobel committee]. I woke up a little after 6 o'clock in the morning and, realising that the announcement must have been made, I opened up my laptop and went to the Nobel Prize website to see who had won. I saw my name and I nudged my wife and said, "I think you'd better look at this".

The work on green fluorescent protein had been widely tipped as a Nobel Prize contender. Would you have been disappointed if you hadn't won at some point?

That's a very hard thing to say. When one does a piece of work that other people enjoy and talk about, you always get some people that come up to you and say: "I really like this work. I think this is a prize-worthy piece of research". If enough people tell that to you, you begin to wonder yourself. And it means you get a little nervous around October.

Why did you start working on GFP?

Since my postdoc in the late 1970s and early 1980s in Sydney Brenner's lab in Cambridge, UK, I have worked on the nematode Caenorhabditis elegans.

Whenever we went out to give seminars about C. elegans, we always spoke about how wonderful the animal was, because it grew quickly, it was small, we knew what the cells were, we had the reconstruction of the lineage and the nervous system. And we always said, "and the animal is transparent".

I first heard about GFP in late 1988, or early 1989 when I attended a seminar by a scientist named Paul Brehm [now at the Vollum Institute, Portland, Oregon]. He described aequorin, the light-producing protein from jellyfish that Shimomura had also discovered, but he also mentioned this fascinating protein called green fluorescent protein.

When somebody who has been saying for 12 years that an animal is transparent hears somebody talk about a fluorescent protein, suggestions come to mind. I immediately thought that this was going to be a way of looking at gene expression and to look at protein localizations. And so I was very excited, in fact I don't remember anything else about Paul's seminar. That's when I first got in touch with Douglas Prasher, because I knew that if we could get this we could use it as a marker for cells and it would be extremely useful.

Douglas Prasher isolated the gene that expresses GFP while he worked at the Woods Hole Oceanographic Institute, Massachusetts, and there have been suggestions that he should have been awarded part of the prize. What is your feeling on that?

My feeling is that yes, he should have been. The problem is that the Nobel Prize is given to a maximum of three people. I would have assumed that the academy debated long and hard about people's contributions.

Douglas was intimately involved. He was the last author on the paper that I published in Science describing the first uses of GFP as a biological marker. He is on the first paper that Roger Tsien published as well. His work was crucial to what we did. So I think his contribution to the science has been massive, and very important. I can only imagine that the selection committee agonized over who should be awarded this prize, with the restriction that they can only have three. I regret that that is the case.

glowing pigsBy injecting GFP into embryonic pigs, researchers managed to breed three male transgenic pigs.National Taiwan University/ REUTERS

Do you have a favourite application of GFP?

Not really. We've used it in many ways in my research to look at gene expression and protein localisation; we've used it as a basis of genetic screens to identify mutations that affect nerve development; we've used it as a way of isolating cells by cell cycle, by fluorescence-activated cell sorting; we've used it as a way of marking cells for electrophysiology.

One proposed application I know that several people have tried is to see if they could hook up bacterial promoters that would respond to increased levels of TNT [trinitrotoluene], and use that to drive the expression of GFP. The idea behind this is that you scatter bacteria or plant seeds [on the ground]; if they fall near a landmine that was leaking TNT, that would allow for the expression of green fluorescence, and one could go at night with a UV lamp and actually see where the TNT was leaking so that people wouldn't be maimed by landmines. That's a very wonderful use if it can be developed.

What's next for you?

I suspect that there'll be a couple more interviews, then things will start to calm down. The funny thing is, some people ask: what are you going to do now? But this was an award for something that we published 14 years ago. We've been doing quite a lot [since then], mainly looking at mechanical sensors on the sense of touch and trying to understand how that's transduced.

We're going to continue to work on that. So I hope that, except for a couple of celebrations, it's going to be fairly normal.

Comments

Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.

  • Without any doubt, also this Nobel Price is worthy! However, in my opinion, today's molecular biological discoveries need too sophysticated, expensive technology, on the one hand, while, on the other hand, their results are far away to be utilised in every day practice on very large scale. For instance, in a paper suggested as CME,authors underline the importance of CRPhs (a biomarker of inflammation) in recognizing the risk of FUTURE diabetes and CAD! It is sufficient to read in www.nature.com my CLINICAL comments on bedside evaluation of diabetic INHERITED Real Risk as well as INHERITED CAD Real Risk, both "conditio sine qua non" of related disorders, for realize that "There are thousands suns above the clouds awaiting us!", as sound an old Indian proverb: www.nature,com, About Biophysical Semeiotic Constitutions http://blogs.nature.com/news/thegreatbeyond/2007/09/acupuncture_better_than_medici_1.html#comments http://blogs.nature.com/wp/nascent/2008/07/plos_one_take_two.html#comments http://blogs.nature.com/nm/spoonful/2008/06/menu_labeling_preaching_to_the.html#comments http://network.nature.com/blogs/user/UE19877E8/2008/02/14/in-which-i-get-roped-in-open-lab-2008 http://blogs.nature.com/news/thegreatbeyond/2008/02/confusion_after_diabetes_study.html#comments http://blogs.nature.com/news/thegreatbeyond/2008/02/confusion_after_diabetes_study.html#comments http://blogs.nature.com/nm/spoonful/2008/03/gout_gene.html http://blogs.nature.com/news/thegreatbeyond/2008/07/hey_pharma_leave_those_kids_al.html#comments http://blogs.nature.com/wp/nascent/2008/07/who_leaves_comments_on_scienti_1.html#comments http://blogs.nature.com/news/thegreatbeyond/2007/09/acupuncture_better_than_medici_1.html#comments http://blogs.nature.com/wp/nascent/2008/07/plos_one_take_two.html#comments http://blogs.nature.com/nm/spoonful/2008/06/menu_labeling_preaching_to_the.html#comments http://network.nature.com/blogs/user/UE19877E8/2008/02/14/in-which-i-get-roped-in-open-lab-2008 http://blogs.nature.com/news/thegreatbeyond/2008/02/confusion_after_diabetes_study.html#comments http://blogs.nature.com/news/thegreatbeyond/2008/02/confusion_after_diabetes_study.html#comments http://blogs.nature.com/nm/spoonful/2008/03/gout_gene.html http://blogs.nature.com/news/thegreatbeyond/2008/07/hey_pharma_leave_those_kids_al.html#comments http://blogs.nature.com/wp/nascent/2008/07/who_leaves_comments_on_scienti_1.html#comments http://www.nature.com/news/2008/081010/full/455845a.html

    • 14 Oct, 2008
    • Posted by: Sergio Stagnaro
  • Many thanks to Nobel Prize Assembly for making very good choices for this year Nobel Prize in Medicine and Chemistry. I cannot imagine what will happen if the Prize goes to iPS cell discovery (which may be counted for medicine since it claims a great value for regenerative medicine or chemistry since it claims a reprogramming of genome). But the reality is that the basic claim of iPS cells ? inducing any adult differentiated cell back to embryonic or embryonic-like stem cell ? has not been proven beyond doubts. But the harm of iPS cells to human health will be real since they are actually Incorrectly Programmed Stem (still iPS) cells that have shown consistent tumorigenicity in all studies reported so far. Shi V. Liu (SVL@logibio.com; http://im1.biz; http://blog.sina.com.cn/im1)

    • 14 Oct, 2008
    • Posted by: Shi Liu

Add your own comment

You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Remember this is for feedback and discussion - not for publishing papers, press releases or advertisements, for example. If you ramble on in an annoying way too often, we may remove your posting privileges.

You need to be registered with Nature to leave a comment. Please log in or register as a new user. You will be re-directed back to this page.